PUT - SPRINTER OPEN END - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 14:05:59 2024-05-15 EDT | ||
| 4.43 EUR | -18.27% |
|
| Current month | -14.91% | ||
| 1 month | -30.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 4.43 | -18.27% |
| 24-05-14 | 5.42 | -1.99% |
| 24-05-13 | 5.53 | -2.98% |
| 24-05-10 | 5.7 | -1.55% |
| 24-05-09 | 5.79 | -1.19% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 02:05 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM017T |
| ISIN | DE000VM017T4 |
| Date issued | 2023-08-09 |
| Strike | 281.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.69 € |
|---|---|
| Lowest since issue | 0.48 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
226.9
USD
Average target price
285.9
USD
Spread / Average Target
+26.02%
- Stock Market
- Certificates
- Certificat